NCT00679965 - Study of Different Doses of a Novel Treatment for Onychomycosis | Biotech Hunter

Enrollment

159

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Distal, Subungual Onychomycosis

Interventions

DRUG

AN2690, 2.5%

Once daily application for 90 days and 3 x weekly for 90 days

DRUG

AN2690, 5%

Once daily application for 90 days and 3 x weekly for 90 days

DRUG

AN2690, 7.5%

Once daily application for 90 days and 3 x weekly for 90 days

DRUG

AN2690 Solution Vehicle

Once daily application for 90 days and 3x weekly for 90 days

Trial Locations (9)

Unidad de Investigación en Salud (UIS), Chihuahua City

"Hospital Dr. Angel Leaño", Guadalajara

Instituto Dermatologico Jalisciense, Guadalajara

Centro Dermatologico Pascua, Mexico City

CIF-BIOTEC Medica Sur., Mexico City

IMIC, Mexico City

Hospital Universitario Dr. José Eleuterio González, Monterrey

MIRC / OCA Hospital, Monterrey

ISSEMYM, Toluca